Sageworth Trust’s Integra LifeSciences IART Stock Holding History

Sageworth Trust’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-41	Closed	-$2.35K	–	242
2023 Q1	$2.35K	Hold	41	–	–	﹤0.01%	441
2022 Q4	$2K	Hold	41	–	–	﹤0.01%	348
2022 Q3	$2K	Hold	41	–	–	﹤0.01%	311
2022 Q2	$2K	Hold	41	–	–	﹤0.01%	343
2022 Q1	$3K	Hold	41	–	–	﹤0.01%	294
2021 Q4	$3K	Sell	41 -139	-77%	-$9.4K	﹤0.01%	509
2021 Q3	$12K	Hold	180	–	–	﹤0.01%	504
2021 Q2	$12K	Buy	+180	New	+$12.7K	﹤0.01%	541

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sageworth Trust's IART Position: Q2 2023 in Review

Sageworth Trust sold out of Integra LifeSciences (IART) in Q2 2023, closing a stake of 41 shares — an estimated $2.35K sold.

Sageworth Trust first reported a position in IART in Q2 2021 and held it in 8 quarters. The position peaked at $12K in Q3 2021. 283 funds tracked by Wall St. Rank hold IART as of Q2 2023.

Sageworth Trust reported no remaining Integra LifeSciences position as of Q2 2023 after selling out during the quarter.
Sageworth Trust sold 41 Integra LifeSciences shares in Q2 2023, an estimated $2.35K.
Sageworth Trust first reported a position in Integra LifeSciences in Q2 2021 and held it in 8 quarters.
Sageworth Trust's Integra LifeSciences position peaked at $12K in Q3 2021.
283 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2023.

Based on Sageworth Trust's 13F filing for Q2 2023, filed 26 Jul 2023.